Literature DB >> 2913032

Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis?

J W Bendig1, P J Mayes, D E Eyers, B Holmes, T T Chin.   

Abstract

A case of peritonitis caused by Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group VE-2) in a patient on continuous ambulatory peritoneal dialysis is reported. This is the seventh case of infection caused by this organism reported in the English literature and the third reported case of continuous ambulatory peritoneal dialysis-related peritonitis caused by this organism; it is the first case of infection of any kind caused by this organism in England.

Entities:  

Mesh：

Year:  1989        PMID： 2913032      PMCID： PMC267271          DOI： 10.1128/jcm.27.1.217-218.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Characteristics of yellow-pigmented nonfermentative bacilli (groups VE-1 and VE-2) encountered in clinical bacteriology.

Authors:  G L Gilardi; S Hirschl; M Mandel
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

2.  Group VE-2 (Chromobacterium typhiflavum) bacteremia.

Authors:  F D Pien
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

3.  Group Ve infection: case report of group Ve-2 septicemia and literature review.

Authors:  F D Pien; E Y Chung
Journal:  Diagn Microbiol Infect Dis       Date:  1986-07       Impact factor: 2.803

4.  Pseudomonas species Ve-2 septicemia.

Authors:  J L Gómez Garcés; J M Aguado; M A Fernández-Clúa; F Soriano
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

5.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

6.  A probability matrix for the identification of gram-negative, aerobic, non-fermentative bacteria that grow on nutrient agar.

Authors:  B Holmes; C A Pinning; C A Dawson
Journal:  J Gen Microbiol       Date:  1986-07

7.  Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  M R Silver; T P Felegie; M I Sorkin
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

8.  The activity of ceftazidime compared with those of aztreonam, newer cephalosporins and Sch 29482 against nonfermentative gram-negative bacilli.

Authors:  R F Schell; M Francisco; J A Bihl; J L LeFrock
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

9.  Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  I J Amber; L G Reimer
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

10.  Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2).

Authors:  J Freney; W Hansen; J Etienne; F Vandenesch; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948
  10 in total
  10 in total

1.  A rare cause of peritonitis caused by Flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis (CAPD).

Authors:  Stamatina Papakonstantinou; Evangelia Dounousi; Kyriakos Ioannou; Ioannis Tsouchnikas; Apostolos Kelesidis; Nikolaos Kotzadamis; Dimitrios Tsakiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Flavimonas oryzihabitans as a cause of ocular infection.

Authors:  P N Levett; D A Garrett; T Wickramasuriya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

3.  Unusual clinical presentation of infection due to Flavimonas oryzihabitans.

Authors:  A Giacometti; O Cirioni; M Quarta; A M Schimizzi; M S Del Prete; G Scalise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

4.  Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child.

Authors:  A Kansouzidou; C Charitidou; E Poubrou; V D Daniilidis; H Tsagaropoulou
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 5.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

6.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Isolation of Flavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient.

Authors:  R Mutters; H Köppler; T Krause
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

Review 8.  Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  A von Graevenitz; D Amsterdam
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

9.  In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Pseudomonas oryzihabitans sepsis in a 1-year-old child with multiple skin rashes: a case report.

Authors:  Michael Owusu; Ellis Owusu-Dabo; Godfred Acheampong; Isaac Osei; John Amuasi; Nimako Sarpong; Augustina Annan; Hsin-Ying Chiang; Chih-Horng Kuo; Se Eun Park; Florian Marks; Yaw Adu-Sarkodie
Journal:  J Med Case Rep       Date:  2017-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.